Delivery Order SPE2DB20D3103-SPE2DB25FP4R1
- Not listed
- The Defense Logistics Agency awarded a $1,424.40 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded transaction. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding agent used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count) valued at $3,964.51. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,987.14 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of September 10, 2025. The award was issued on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $2,716.20 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Veltassa 8.4 GM powder packets (quantity 30). This competitively awarded, firm fixed-price contract is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,565.83 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 10, 2025, for Veltassa 8.4 GM powder packets (30-count) with a ceiling value of $2,037.15 under firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $14,202.32 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime...
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count) under a firm fixed-price contract valued at $2,469.40, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a procurement of pharmaceutical products for military healthcare needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,609.85 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This competitively awarded, firm fixed-price delivery order is set to be completed by August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used in the management of hyperkalemia, a condition relevant to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4R1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,173.79 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Veltassa, a potassium-binding agent used primarily in the treatment of hyperkalemia, represents one of the specialized pharmaceutical products the company supplies through its extensive federal contract portfolio. The DLA Troop Support Medical contract serves as a comprehensive vehicle for delivering prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military readiness and patient care initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/10/25 |